Accelerate your clinical trials with Biorce's AI-powered platform. Learn how we help pharma, CROs and biotech companies run faster and more efficient trials.
Location: Spain
Total raised: $58.35M
Investors 1
| Date | Name | Website |
| 27.12.2024 | YZR Ventur... | yzr.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.02.2026 | Series A | $52.5M | YZR |
| 09.07.2025 | - | $5.85M | Norrsken V... |
Mentions in press and media 18
| Date | Title | Description |
| 03.02.2026 | Prometheum Fuels U.S. Digital Market Expansion with $23 Million Capital Infusion | Prometheum secured $23 million in fresh capital from diverse investors, boosting its U.S. digital asset market expansion. This funding accelerates efforts to modernize digital asset distribution within established U.S. securities markets. T... |
| 03.02.2026 | Biorce Secures $52.5M, Propels AI Clinical Trial Revolution | Biorce, a Barcelona-based AI health leader, closed a landmark $52.5M Series A funding. This capital fuels global expansion and product development. Its Aika platform revolutionizes clinical trials. Aika leverages AI to optimize trial design... |
| 03.02.2026 | Biorce: $52.5 Million Series A Raised To Expand Globally And Apply AI to Clinical Trial Design | Biorce, a Barcelona-based health AI company focused on using artificial intelligence to improve how clinical trials are designed and executed, announced it has closed a $52.5 million Series A round to accelerate international expansion and ... |
| 02.02.2026 | Prometheum Raises Additional $23M in Funding | Prometheum, a NYC-based market infrastructure provider for digital assets, raised additional $23M in funding. Backers were not disclosed. The company intends to use the funds to support its commercial expansion as it brings digital asset pr... |
| 02.02.2026 | Barcelona-based Biorce closes €43.8 million Series A to accelerate AI-driven clinical trials | Biorce, a Barcelona-based HealthTech company transforming clinical trials through artificial intelligence, has today announced the closing of a €43.8 million ($52 million) Series A round to support international expansion, hire and accelera... |
| 02.02.2026 | Biorce raises $52M to support global rollout of its AI clinical trial platform | Barcelona-based Biorce, a health AI company focused on clinical trial design and execution, has closed a $52 million Series A round. The financing includes new investment from DST Global Partners, with existing investors Norrsken VC and YZR... |
| 02.02.2026 | Biorce closes $52.5 million Series A to accelerate international expansion and lead the transformation of clinical trials through AI | Biorce, a Barcelona-based health AI company specialized in applying artificial intelligence to the design and execution of clinical trials, has closed a $52.5 million Series A round. The financing includes new investment from DST Global Par... |
| 02.02.2026 | Biorce closes $52.5MM Series A to accelerate international expansion, lead transformation of clinical trials through AI | Our mission is to make clinicaltrials faster, more reliable, and more accessible, so patients can benefit from new treatments sooner. ” — Pedro Coelho, CEO, BiorceBARCELONA, SPAIN, February 2, 2026 /EINPresswire.com/ -- Biorce, a Barcelona-... |
| 30.01.2026 | Spain’s rising tech scene: 10 of the most promising startups driving change in 2026 | Following our series of country articles, today we turn our attention to Spain’s innovation landscape, exploring the factors shaping its startup ecosystem and highlighting the momentum behind a new generation of fast-growing technology comp... |
| 10.07.2025 | Healthtech Pioneer Biorce Secures €5M for Global Clinical Trial Acceleration | Biorce, a Barcelona healthtech firm, secured €5M from Norrsken VC. This capital fuels its AI platform, revolutionizing clinical trials. The technology streamlines drug development, cutting delays and costly amendments. It speeds new therapi... |
Show more